About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc
targeted mutation 5, Mario R Capecchi
MGI:5649273
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc/Gt(ROSA)26Sortm1(cre/ERT)Nat involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5649275
cn2
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc/Gt(ROSA)26Sor+
Tg(Prrx1-cre/ERT2)1Mlgn/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5649279


Genotype
MGI:5649275
cn1
Allelic
Composition
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc/Gt(ROSA)26Sortm1(cre/ERT)Nat
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(cre/ERT)Nat mutation (2 available); any Gt(ROSA)26Sor mutation (993 available)
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop a tumor within the skull between 3 and 6 months of age; tumors are found primarily in the brain parenchyma, but also in the choroid plexus and orbit
• tumors show characteristic nests of polygonal cells with an open chromatin pattern, surrounded by neatly arcading capillary and larger vascular channels, resembling alveolar soft part sarcoma
• tumors often arise in or near the leptomeninges, along sulci
• some tumors show aggressive invasive growth, with extensions of tumor cells into the cerebellum, cerebrum, and the vessels of the choroid plexus
• mice do not develop tumors in the skeletal muscle
• tumors form in the areas highest in lactate, the cranial vault, express high levels of lactate importers, have abundant mitochondria, metabolize lactate as a metabolic substrate, and respond to exogenous lactate administration with increased cell proliferation and angiogenesis

craniofacial
• mice often exhibit enlargement of the occipital bone from the inner soft tissue expansion

skeleton
• mice often exhibit enlargement of the occipital bone from the inner soft tissue expansion

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
alveolar soft part sarcoma DOID:4239 OMIM:606243
J:217462




Genotype
MGI:5649279
cn2
Allelic
Composition
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc/Gt(ROSA)26Sor+
Tg(Prrx1-cre/ERT2)1Mlgn/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm5(ASPSCR1/TFE3)Mrc mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(Prrx1-cre/ERT2)1Mlgn mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop intracranial tumors 10-14 weeks after tamoxifen treatment at 2 weeks of age
• tumors are located either within the brain parenchyma or it the periosteum along the inner table of the cranium
• however, no tumors are seen in the outer table periosteum or the limbs





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory